What is Breo Ellipta
VilanterolThe Generic name of this drug
Treatment SummaryVilanterol is a long-acting medication used to treat COPD (chronic obstructive pulmonary disease) and asthma. It works by increasing the production of a chemical messenger in the lungs that helps relax the airways and prevent the release of substances that can cause allergic reactions. It is approved for use in combination with other drugs such as fluticasone furoate (under the brand name Breo Ellipta) and umeclidinium bromide (under the brand name Anoro Ellipta). Vilanterol was approved by the FDA in 2013 and is used to treat breathing problems caused by
Breo Elliptais the brand name
Breo Ellipta Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Breo Ellipta
Vilanterol
2013
12
Effectiveness
How Breo Ellipta works in the bodyVilanterol helps people with breathing problems by relaxing the muscles in their lungs and blocking the release of substances that cause swelling and inflammation. It does this by stimulating a process in the body that converts energy into a chemical which helps relax the muscles.
When to interrupt dosage
The proposed dosage of Breo Ellipta is contingent upon the ascertained condition. The quantity of dosage relies on the technique of delivery noted in the table below.Condition
Dosage
Administration
Asthma
0.022 mg, , 0.025 mg, 0.025 mg/pump actuation
, Powder, Respiratory (inhalation), Powder - Respiratory (inhalation), Powder, metered - Respiratory (inhalation), Powder, metered
Chronic Obstructive Pulmonary Disease
0.022 mg, , 0.025 mg, 0.025 mg/pump actuation
, Powder, Respiratory (inhalation), Powder - Respiratory (inhalation), Powder, metered - Respiratory (inhalation), Powder, metered
Warnings
Breo Ellipta ContraindicationsCondition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Vilanterol may interact with Toxoplasma Infections
Not being treated with an inhaled corticosteroid
Do Not Combine
Severe Hypersensitivity Reactions
Do Not Combine
Vilanterol may interact with Toxoplasma Infections
Common Breo Ellipta Drug Interactions
Drug Name
Risk Level
Description
9-(N-methyl-L-isoleucine)-cyclosporin A
Major
The risk or severity of adverse effects can be increased when Vilanterol is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Acteoside
Major
The risk or severity of adverse effects can be increased when Vilanterol is combined with Acteoside.
Anifrolumab
Major
The risk or severity of adverse effects can be increased when Vilanterol is combined with Anifrolumab.
Antilymphocyte immunoglobulin (horse)
Major
The risk or severity of adverse effects can be increased when Vilanterol is combined with Antilymphocyte immunoglobulin (horse).
Avacopan
Major
The risk or severity of adverse effects can be increased when Vilanterol is combined with Avacopan.
Breo Ellipta Novel Uses: Which Conditions Have a Clinical Trial Featuring Breo Ellipta?
244 active clinical trials are currently assessing the potential of Breo Ellipta as a therapeutic option for Asthma.Condition
Clinical Trials
Trial Phases
Chronic Obstructive Pulmonary Disease
104 Actively Recruiting
Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4
Asthma
152 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3, Early Phase 1
Breo Ellipta Reviews: What are patients saying about Breo Ellipta?
5Patient Review
3/30/2020 I had asthma my whole life, but it became much worse after living in China. Once I started taking Breo 200/25, though, it was like a weight had been lifted off my chest. I could finally breathe again.
5Patient Review
2/13/2021 This medication, in combination with Spiriva, has done wonders for my COPD. I can breath so much better now and don't feel nearly as short of breath.
4Patient Review
10/17/2020 I started taking this medication after Spiriva Ives stopped being effective. Breo does seem to work, but it comes with a range of uncomfortable side effects, including a sore throat, nasal congestion, back pain, and shortness of breath. Additionally, I've had heart palpitations while on the drug. It seems to work better after about an hour after use; however, the side effects are still present. I'm not sure if I will continue using it and may talk to my lung doctor about other options.
4Patient Review
10/25/2020 After a few years on Spiriva, I switched to Breo. While it initially worked well for me, it eventually stopped being effective. However, I've found that Breo has helped me to breathe more deeply. The side effects (hoarseness, throat-clearing, and nose stuffiness) are a bit annoying but the benefits of the medication outweigh them.
4Patient Review
8/23/2021 I wanted to add that, in my experience, it doesn't seem to matter what medication you're taking for COPD. I found that adding an acid controller helped me feel much better while on Breo.
3Patient Review
3/18/2020 Worked just as well as Symbicort, but after only three months I developed bronchial asthma. So it's not worth it in the long run.
2.7Patient Review
5/15/2020 I've been on this medication for 25 years and it really tightens my muscles and gives me leg cramps. Unfortunately, there are no other options available to me.
2.7Patient Review
9/13/2022 For the last five days of treatment with Breo Ellipta, I experienced a severe cough that interrupted my daily activities. I believe that GSK is cutting corners by not providing full doses of the medication, which costs patients a lot of money.
1.7Patient Review
7/28/2019 I developed some serious complications after starting this medication, including hoarseness, difficulty swallowing, and burning mouth syndrome. My doctor took me off the Breo for 10 days to see if that would help; thankfully, I'm already feeling some relief.
1.3Patient Review
6/6/2021 I experienced burning in both lungs while using this medication, to the point where I had to sit on oxygen a lot. Xopenex provided some relief, but only for one inhalation. I'm praying for answers for all of us who are struggling with this medication. It should be reported to the FDA.
1Patient Review
2/28/2020 I started using the Breo inhaler on Feb. 15, 2020, but after only two weeks of daily use I'm discontinuing. My doctor advised me to stop because I experienced chest tightness, palpitations, daily headaches, severe back pain, leg cramps, and sweating--none of which are symptoms related to my asthma. In short: this medication did not help me at all and made me feel worse in general.
1Patient Review
4/6/2022 I didn't see any improvement after using this treatment.
1Patient Review
10/9/2022 This is complete garbage and I have no idea how it ever made it to market. It's expensive and dangerous, and the people responsible for this should be held accountable.
Patient Q&A Section about breo ellipta
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is Breo for asthma or COPD?
"Breo Ellipta 100/25 will not replace a rescue inhaler.
Breo Ellipta is used to treat COPD and asthma as follows: Breo Ellipta 100/25 is a prescription medicine used to treat COPD. COPD is a chronic lung disease that includes chronic bronchitis, emphysema, or both. Breo Ellipta 100/25 will not replace a rescue inhaler."
Answered by AI
What is Breo Ellipta used for?
"This can make breathing difficult.
Asthma and COPD are two conditions that can be treated using BREO ELLIPTA. The medication is inhaled through the mouth using the ELLIPTA inhaler. With asthma, the muscles surrounding the small airways can become tight, swollen, and irritated, making it difficult to breathe."
Answered by AI
Is Breo a steroid inhaler?
"Breo Ellipta is a inhalation powder that contains a combination of fluticasone and vilanterol. Fluticasone is a steroid that prevents the release of substances in the body that cause inflammation."
Answered by AI
What is the side effect of Breo Ellipta?
"Side effects that are common when taking BREO 100/25 for COPD include a runny nose and sore throat, upper respiratory tract infection, headache, and thrush in your mouth or throat."
Answered by AI